Topical Corticosteroids – Potency Comparison Table
General rule: Use the lowest effective potency for the shortest duration, especially on the face, groin, axillae, and in children.
| Potency Class | Potency Level | Generic Name | Common Brand Names | Typical Indications | Safe Use Areas | Key Pharmacist Pearls |
|---|---|---|---|---|---|---|
| Class I | Super-potent | Clobetasol propionate 0.05% | Dermovate®, Clobex® | Severe psoriasis, lichen planus, discoid lupus | Thick skin only (palms, soles) | Limit to ≤2 weeks; high risk of skin atrophy and HPA axis suppression |
| Class II | High | Betamethasone dipropionate 0.05% (augmented) | Diprolene® | Severe eczema, psoriasis | Trunk, extremities | Avoid face/groin; occlusion ↑ absorption |
| Class III | High | Fluocinonide 0.05% | Lidex® | Chronic inflammatory dermatoses | Trunk, extremities | Use short courses |
| Class IV | Medium–high | Mometasone furoate 0.1% | Elocon® | Moderate eczema, dermatitis | Trunk, limbs | Once-daily dosing sufficient |
| Class V | Medium | Triamcinolone acetonide 0.1% | Kenalog® | Atopic dermatitis, contact dermatitis | Trunk, limbs | Avoid prolonged use on face |
| Class VI | Low | Desonide 0.05% | Desowen® | Mild eczema, facial dermatitis | Face, intertriginous areas | Safe for children short-term |
| Class VII | Least potent | Hydrocortisone 1–2.5% | Cortate®, OTC hydrocortisone | Mild inflammation, insect bites | Face, groin, infants | Lowest risk of adverse effects |
Vehicle Strength Matters (High-Yield Tip)
| Vehicle | Relative Potency |
|---|---|
| Ointment | Highest |
| Cream | Moderate |
| Lotion | Lower |
| Gel/Foam | Variable (good for scalp) |
Same steroid + different vehicle = different clinical effect
Safety & Counseling Pearls for Pharmacists
- Fingertip unit (FTU): 1 FTU ≈ 0.5 g covers ~2 adult palm areas
- Avoid occlusion unless directed (dramatically increases absorption)
- Watch for local adverse effects:
- Skin atrophy
- Telangiectasia
- Striae
- Systemic effects possible with:
- High potency
- Large surface area
- Prolonged use
- For chronic disease, consider steroid-sparing agents (tacrolimus, pimecrolimus)

